Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 38 for “"Circulating cell free DNA"”.
-
Characterisation of Circulating Cell-free DNA in Women and Implications for the Development of an Ovarian Cancer Screening Test
… is therefore imperative for reducing mortality. Circulating cell-free DNA (cirDNA) is a promising biomarker for non-invasive population-wide OC screening, however, a clinically useful test requires highly optimised sensitivity and specificity. This thesis investigated potential artefacts of …
-
Investigating the role of circulating cell-free dna as a mechanistic biomarker in inflammatory bowel disease: development of an integrated precision-medicine enabled platform in Scotland
BACKGROUND: Circulating cell-free DNA (cfDNA) represents a class of biological molecules whose role in inflammation remains poorly understood. Inflammatory bowel disease (IBD), from ulcerative colitis to Crohn’s disease, comprises a spectrum of chronic immune-mediated conditions with complex …
-
A Method for Identification of Pancreatic Cancer through Methylation Signatures in Cell-Free DNA
… it can spread throughout the body. Evaluation of circulating cell-free DNA (cfDNA), specifically, detection of circulating tumor DNA (ctDNA), is being explored as an approach for non-invasive ‘liquid biopsy’ that can be deployed widely and cost-effectively to screen for early signs of disease. DNA …
-
CELL-FREE DNA PROFILING REVEALS MECHANISMS OF ANTI-EGFR DRUG RESISTANCE IN COLORECTAL CANCER
Circulating cell-free DNA (cfDNA) provides a minimally invasive platform for the molecular profiling of cancer. Here, we applied cfDNA to investigate both genetic alterations and inferred transcriptomic profiles in metastatic colorectal cancer (mCRC) patients treated with anti-EGFR antibodies. …
-
STATISTICAL METHODS FOR CANCER RESEARCH: EARLY DETECTION, META-ANALYSIS, AND RISK FACTOR ASSESSMENT
… that can be used to analyze the fragmentation of circulating cell-free DNA as an early biomarker for cancer (Chapter 2). We then provide an analysis comparing two DNA sequencing techniques in their ability to capture differences between cancer and non-cancer blood samples. In Chapter 3, we develop …
-
MONITORING CANCER USING GENOME-WIDE CELL-FREE DNA FRAGMENTOMES
… Furthermore, the currently available circulating cell-free DNA (cfDNA) assays require deep-targeted sequencing to detect cancer-specific mutations or methylation profiles at low mutant allele frequency (MAF) levels. This study presents a tumor-agnostic approach that is not dependent on …
-
Early microcirculatory dysfunction following traumatic haemorrhage
… It is also associated with higher levels of circulating cell-free DNA (cfDNA), supporting the hypothesis that cfDNA is an aetiological factor in this pathological response. Both endotheliopathy and elevated cfDNA and are related to poor clinical outcomes. In Part II, clinical implications of …
-
Η σημασία της γήρανσης των ηπατοκυττάρων στη φυσική ιστορία της χρόνιας λοίμωξης με ιό Ηπατίτιδας Β
… infection is a serious medical issue, worldwide. Circulating cell-free DNA (cfDNA) and global DNA methylation, which is expressed as circulating levels of 5-methyl-2’-deoxycytidine, applying the liquid biopsy approach, seem to be linked to epigenetic changes and senescence. This study aims to …
-
Investigating the utility of blood borne oncological biomarkers in solid tumours: glioma and melanoma
… into the potential utility of these circulating biomarkers as analytic test measures complementing radiological imaging have been occasioned by the invasive nature of malignant tumour tissue biopsy, the need for serial evaluation of tumour burden during therapy, and the need for …
-
Probabilistic modeling of high-throughput sequencing data for enhanced understanding of DNA methylation heterogeneity
DNA methylation is a key epigenetic mechanism governing gene regulation and cellular identity. Advances in high-throughput sequencing technologies have enabled detailed investigation of methylation landscapes across single cells and complex tissue mixtures. However, the sparsity and noise inherent …
-
Characterising peripheral responses to immune checkpoint inhibitors
… biomarkers which can be assessed in a biopsy-free manner may facilitate early detection of non-responders and optimal targeting of treatment.</p> <p>There is emerging evidence to show that the circulating monocyte population has a prognostic and predictive role in the context of ICB, but this …
-
Whole-genome copy-number profile analysis as a biomarker of relapse in melanoma
… utility of whole-genome copy-number profiles in circulating cell-free DNA (cfDNA), as a marker of melanoma relapse. We adapted two published copy-number aberration scoring algorithms, the Copy Number Aberration Score (CNAS) and Extreme Copy Number Aberration Score (eCNAS), exploring their utility …
-
Quantitative analyses to study tumor clones dynamics and tumor heterogeneity
… to serial sampling. Liquid biopsies contain circulating cell free DNA (cfDNA) released from widespread tumor cells, potentially uncovering the full tumor landscape. By using next generation sequencing on cfDNA obtained from plasma, I developed strategies aimed at systematically tracking the …
-
GENOME-WIDE ANALYSES OF CELL-FREE DNA FOR THERAPEUTIC MONITORING OF PATIENTS WITH PANCREATIC CANCER
… methods for assessing response to therapy using circulating cell-free DNA (cfDNA) in patients with metastatic pancreatic cancer treated with immune checkpoint inhibition and radiation as part of the CheckPAC trial (NCT02866383). Samples were evaluated after initiation of therapy and mutant allele …
-
Optimization of the detection of circulating DNA in pediatric solid tumor patients treated with granulocyte colony stimulating factor
… and/or to mobilize hematopoietic stem cells from the bone marrow into the blood for ease of collection. Previous in vivo studies in mice showed, that G-CSF can increase tumor growth and promote metastasis. As such, this study investigated whether G-CSF can promote tumor growth in …
-
Discovery of Novel Circulating Biomarkers in Metastatic Castration Resistant Prostate Cancer to Guide Optimal Treatment Decisions
Circulating cell free DNA (cfDNA) is emerging as a key tool to identify treatment resistance in metastatic castration resistant prostate cancer (mCRPC). Numerous studies have reported specific genomic aberrations, including androgen receptor mutations and splice variants, associated with resistance …
Page 1 of 2